{"id":"https://openalex.org/W2736896207","doi":"https://doi.org/10.1182/blood.v128.22.46.46","title":"BET Bromodomain Inhibition Selectively Targets the Epstein-Barr Virus Oncogene LMP1 While Promoting Virus-Specific, Adaptive Anti-Tumor Activity","display_name":"BET Bromodomain Inhibition Selectively Targets the Epstein-Barr Virus Oncogene LMP1 While Promoting Virus-Specific, Adaptive Anti-Tumor Activity","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2736896207","doi":"https://doi.org/10.1182/blood.v128.22.46.46","mag":"2736896207"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.46.46","doi":"https://doi.org/10.1182/blood.v128.22.46.46","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.46.46","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108521053","display_name":"Emily E. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Emily Smith","raw_affiliation_strings":["The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003381938","display_name":"Andrew R. Stiff","orcid":"https://orcid.org/0000-0003-4154-4461","observed_orcids":["https://orcid.org/0000-0003-4154-4461"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Stiff","raw_affiliation_strings":["College of Medicine, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Medicine, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John T. Patton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John T. Patton","raw_affiliation_strings":["Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH","institution_ids":["https://openalex.org/I2802841970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060897770","display_name":"William Edgar Carson","orcid":"https://orcid.org/0000-0001-7024-7533","observed_orcids":["https://orcid.org/0000-0001-7024-7533"]},"institutions":[{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"William Carson","raw_affiliation_strings":["Department of Surgery, The Ohio State University Wexner College of Medicine, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, The Ohio State University Wexner College of Medicine, Columbus, OH","institution_ids":["https://openalex.org/I2802841970","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023800287","display_name":"Rosa Lapalombella","orcid":"https://orcid.org/0000-0001-6916-9400","observed_orcids":["https://orcid.org/0000-0001-6916-9400"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rosa Lapalombella","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012846289","display_name":"Robert A. Baiocchi","orcid":"https://orcid.org/0000-0002-1619-4853","observed_orcids":["https://orcid.org/0000-0002-1619-4853","https://orcid.org/0000-0002-6518-8169"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A Baiocchi","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5060897770","https://openalex.org/A5108521053"],"corresponding_institution_ids":["https://openalex.org/I2802841970","https://openalex.org/I52357470"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.22118106,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"128","issue":"22","first_page":"46","last_page":"46"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.864300012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.864300012588501,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.11649999767541885,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epstein-barr-virus","display_name":"Epstein-Barr virus","score":0.9940000176429749},{"id":"https://openalex.org/keywords/lmp1","display_name":"LMP1","score":0.8980000019073486},{"id":"https://openalex.org/keywords/brd4","display_name":"BRD4","score":0.9279999732971191},{"id":"https://openalex.org/keywords/bet-bromodomain-inhibition","display_name":"BET bromodomain inhibition","score":0.890999972820282},{"id":"https://openalex.org/keywords/jq1","display_name":"JQ1","score":0.9940000176429749},{"id":"https://openalex.org/keywords/lymphoproliferative-disorders","display_name":"lymphoproliferative disorders","score":0.8270000219345093},{"id":"https://openalex.org/keywords/b-cell-transformation","display_name":"B cell transformation","score":0.7960000038146973},{"id":"https://openalex.org/keywords/prmt5","display_name":"PRMT5","score":0.6919999718666077},{"id":"https://openalex.org/keywords/epigenetic-readers","display_name":"epigenetic reader protein","score":0.6539999842643738},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.3840000033378601},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.6859999895095825},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.5989999771118164},{"id":"https://openalex.org/keywords/ebv-transformed-lymphoblastoid-cell-lines","display_name":"EBV-transformed lymphoblastoid cell lines","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C2779634854","wikidata":"https://www.wikidata.org/wiki/Q18037206","display_name":"BRD4","level":5,"score":0.782454788684845},{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.781320333480835},{"id":"https://openalex.org/C2781375147","wikidata":"https://www.wikidata.org/wiki/Q6900","display_name":"Epstein\u2013Barr virus","level":3,"score":0.6699793338775635},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6515491008758545},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.6126527786254883},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.583420991897583},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4632490873336792},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3562067151069641},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16844111680984497},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.14278638362884521}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.46.46","doi":"https://doi.org/10.1182/blood.v128.22.46.46","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.46.46","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.6100000143051147,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2623774699","https://openalex.org/W2951344251","https://openalex.org/W4310160027","https://openalex.org/W2038360275","https://openalex.org/W187824967","https://openalex.org/W1964664555","https://openalex.org/W2923979374","https://openalex.org/W1986903316","https://openalex.org/W3095722479","https://openalex.org/W7096100178"],"abstract_inverted_index":{"Abstract":[0],"Epstein-Barr":[1],"virus":[2],"(EBV)":[3],"is":[4,17,40,142,437,589],"a":[5,20,104,178,196,231,247,270,277,286,306,544,554],"human":[6],"herpesvirus":[7],"that":[8,101,110,126,146,156],"infects":[9],"over":[10],"90%":[11],"of":[12,22,35,58,92,122,154,167,202,228,236,250,253,261,273,279,289,330,342,350,359,372,383,405,414,465,497,506,547,579,603],"the":[13,33,90,165,186,200,328,340,348,357,367,370,384,461,504,575,601,604],"world's":[14],"population":[15,299,346],"and":[16,39,51,69,114,125,135,151,160,174,189,259,281,313,430,444,463,484,523,529,553,577],"associated":[18],"with":[19,66,239,409,458,619],"wide-range":[21],"diseases.":[23],"EBV":[24,120,375,385,459,482],"has":[25],"evolved":[26],"to":[27,42,86,169,198,218,302,354,381,412,519,613],"manipulate":[28],"host":[29,534,566,605],"cellular":[30],"networks":[31,417],"in":[32,204,230,246,276,309,347,369,400,407,460,474,478,559,616],"absence":[34,464],"proper":[36],"immune":[37,266,362,536,556,606,622],"function":[38],"linked":[41],"malignant":[43,597],"lymphoproliferative":[44,206],"disorders":[45],"(LPD)":[46],"such":[47],"as":[48,103,177,195,300,391,393,508,516,543,594],"Hodgkin's":[49],"lymphoma":[50],"diffuse":[52],"large":[53],"B-cell":[54],"lymphomas.":[55],"The":[56,133,402],"lack":[57],"standard":[59],"or":[60],"effective":[61],"therapeutic":[62,131,180,511,592],"approaches":[63],"for":[64,182,439,513],"individuals":[65],"these":[67,127,539],"aggressive":[68],"clinically":[70],"complicated":[71],"diseases":[72],"represents":[73],"an":[74,98,143,509,590,610],"important":[75],"unmet":[76],"need.":[77],"We":[78,108,184],"have":[79],"recently":[80],"demonstrated":[81],"EBV-induced":[82],"B":[83,123,171,441,454,526,561],"cell":[84,158,172,214,332,345,442,486,527,548,572,621],"transformation":[85,173,476,496],"be":[87,614],"dependent":[88],"upon":[89],"dysregulation":[91],"protein":[93,138,389],"arginine":[94],"methyltransferase":[95],"5":[96],"(PRMT5),":[97],"epigenetic":[99,111,144],"writer":[100],"functions":[102,518],"global":[105],"transcriptional":[106],"repressor.":[107],"hypothesize":[109],"readers,":[112],"writers":[113],"erasers":[115],"are":[116],"similarly":[117],"dysregulated":[118],"following":[119,481],"infection":[121,483],"cells":[124,455,598],"enzymes":[128],"represent":[129],"novel":[130],"candidates.":[132],"bromodomain":[134,139],"extra-terminal":[136],"(BET)":[137],"4":[140],"(BRD4)":[141],"reader":[145],"binds":[147],"acetylated":[148],"lysine":[149],"residues":[150],"promotes":[152],"transcription":[153],"genes":[155],"drive":[157],"growth":[159],"survival.":[161],"Here,":[162],"we":[163,337,364,446],"evaluate":[164],"relevance":[166,201],"BRD4":[168,191,203,378,542],"EBV-driven":[170,205,440,495,514],"identify":[175,541],"it":[176,517,595,609],"potential":[179,555],"target":[181,520],"EBV-LPD.":[183],"used":[185,615],"highly":[187,373],"selective":[188],"potent":[190],"inhibitor":[192],"(BRD4i),":[193],"JQ1,":[194],"model":[197],"examine":[199],"disease":[207],"(LPD).":[208],"JQ1":[209,229,274,466],"treatment":[210],"of,":[211],"EBV-transformed":[212],"lymphoblastoid":[213],"lines":[215],"(LCLs)":[216],"led":[217,380,411],"reduced":[219],"proliferation,":[220],"but":[221],"not":[222],"direct":[223],"cytotoxicity.":[224],"However,":[225],"similar":[226],"concentrations":[227],"more":[232],"physiologically-relevant":[233],"co-culture":[234,278],"setting":[235],"EBV-LCLs":[237],"cultured":[238],"autologous":[240,282],"peripheral":[241],"blood":[242],"lymphocytes":[243],"(PBMC),":[244],"resulted":[245],"robust":[248],"depletion":[249,329],"LCLs,":[251],"loss":[252],"suppressive":[254,314,570],"myeloid":[255,315,331,571],"populations":[256,316,573],"(TAM/M2":[257],"phenotype)":[258],"expansion":[260,288,578],"anti-tumor":[262,533],"adaptive,":[263],"memory":[264,292,580],"CD3/CD8":[265],"effector":[267,291],"cells.":[268,584],"Using":[269],"single":[271],"dose":[272],"(500nM)":[275],"LCLs":[280,312,408],"PBMCs,":[283],"there":[284],"was":[285,322,472],"marked":[287],"activated,":[290],"(CD3+,":[293],"CD8+,":[294],"CD45RO+,":[295],"CD62L-)":[296],"cytotoxic":[297,343,582],"T-cell":[298],"compared":[301],"vehicle-treated":[303],"co-cultures.":[304],"Furthermore,":[305,563],"dramatic":[307],"reduction":[308],"both":[310],"CD19+":[311],"(CD33+,":[317],"CD11b,":[318],"HLADR+,":[319],"CD206+,":[320],"PD-L1+)":[321],"observed":[323],"after":[324],"10":[325],"days.":[326],"Despite":[327],"subsets":[333],"by":[334,419,568],"CD33":[335],"depletion,":[336],"still":[338],"saw":[339],"outgrowth":[341,528],"T":[344,583,620],"presence":[349,462],"JQ1.":[351],"In":[352],"order":[353],"delve":[355],"into":[356],"causes":[358],"this":[360,420],"heightened":[361],"response,":[363],"looked":[365],"at":[366],"changes":[368],"expression":[371,404],"immunogenic":[374],"specific":[376],"proteins.":[377],"inhibition":[379],"upregulation":[382],"oncoprotein,":[386],"latent":[387],"membrane":[388],"1(LMP1),":[390],"well":[392],"MHC":[394],"class":[395],"I":[396],"antigen":[397],"presentation":[398],"machinery":[399],"LCLs.":[401],"enhanced":[403],"LMP1":[406,434],"BRD4i,":[410],"modulation":[413],"downstream":[415],"signaling":[416],"driven":[418],"oncogene":[421,551],"including":[422],"PI3K/pAKT":[423],"(decreased),":[424],"NF-\u0138B":[425],"(canonical":[426],"down/non":[427],"canonical":[428],"up)":[429],"pSTAT3":[431],"(decreased).":[432],"Because":[433],"oncogenic":[435],"activity":[436],"vital":[438],"immortalization":[443],"transformation,":[445],"next":[447],"conducted":[448],"in-vitro":[449],"assays":[450],"where":[451],"primary,":[452],"na\u00efve":[453,499],"were":[456,488],"infected":[457],"(50,":[467],"500nM)":[468],"treatment.":[469],"Selective":[470],"BRD4i":[471,493,507,564,588],"introduced":[473],"separate":[475],"cultures":[477],"seven-day":[479],"intervals":[480],"absolute":[485],"counts":[487],"monitored.":[489],"At":[490],"all":[491],"timepoints":[492],"prevented":[494],"purified":[498],"B-lymphocytes.":[500],"Our":[501],"findings":[502],"highlight":[503],"utility":[505],"experimental":[510],"strategy":[512,593],"lymphomas":[515],"pathways":[521],"initiating":[522],"sustaining":[524],"transformed":[525,560],"survival":[530],"while":[531,599],"supporting":[532],"memory,":[535],"networks.":[537],"Collectively,":[538],"experiments":[540],"key":[545],"driver":[546],"cycle":[549],"progression,":[550],"activation,":[552],"checkpoint":[557],"modulator":[558],"lymphoblasts.":[562],"enhances":[565],"immunity":[567],"eliminating":[569],"permitting":[574],"activation":[576],"CD3+/CD8+":[581],"This":[585],"work":[586],"demonstrates":[587],"attractive":[591],"sensitizes":[596],"enhancing":[600],"responsiveness":[602],"system,":[607],"making":[608],"ideal":[611],"candidate":[612],"future":[617],"trials":[618],"therapies.":[623],"Disclosures":[624],"Baiocchi:":[625],"Essanex:":[626],"Research":[627],"Funding.":[628]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2017-07-31T00:00:00"}